Medicine and Dentistry
COVID-19 Vaccine
77%
Adverse Event
52%
Dual-Energy X-Ray Absorptiometry
51%
Adipose Tissue
45%
Skinfold
40%
COVID-19
32%
Hydration Status
27%
Human Milk
22%
Menstrual Cycle
22%
Milk Ejection
22%
Periprosthetic Joint Infection
22%
Acid
22%
Bacterial DNA
22%
Implant
22%
Debridement
22%
Controlled Clinical Trial
22%
Antibiotics
22%
Endurance Training
18%
Severe Acute Respiratory Syndrome Coronavirus 2
15%
Resistance Training
13%
Urinary System
12%
Immunocompromised Patient
12%
Infectious Arthritis
11%
Prosthetics
11%
Absorptiometry
11%
Dehydration
11%
Immunogenicity
10%
Client
10%
Body Composition Assessment
10%
Booster Dose
10%
Infection
9%
Vaccine
9%
Myalgia
9%
Anaphylaxis
9%
Headache
9%
Surveillance System
9%
COVID-19 Vaccination
7%
Microbiome
6%
Human Immunodeficiency Virus
6%
Transplantation
6%
Immunoglobulin G
6%
Hematologic Malignancy
6%
Clinical Trial
6%
Water Intake
5%
Reactogenicity
5%
Pharmacology, Toxicology and Pharmaceutical Science
COVID-19 Vaccine
100%
Immunogenicity
71%
Adverse Event
52%
Clinical Trial
49%
SARS Coronavirus
43%
Messenger RNA
27%
Periprosthetic Joint Infection
22%
Implant
22%
Lactose
22%
Controlled Clinical Trial
22%
Antibiotics
22%
Immunocompromised Patient
12%
Infectious Arthritis
11%
mRNA Vaccine
11%
Neutralizing Antibody
11%
Immunoglobulin
11%
Uranium 234
11%
Infection
9%
Headache
9%
Vaccine
9%
Myalgia
9%
Anaphylaxis
9%
Coronavirinae
7%
Monoclonal Antibody
6%
HIV
6%
Immunoglobulin G
6%
Hematologic Malignancy
6%
Nursing and Health Professions
Dual Energy X Ray Absorptiometry
68%
Body Composition
60%
Fluid Intake
27%
Nipple Shield
22%
Mastalgia
22%
Implant
22%
Bloodstream Infection
22%
Debridement
22%
Lactose
22%
Diseases
22%
Joint Prosthesis
17%
Dehydration
15%
Fat Mass
15%
Confidence Interval
13%
Client
12%
Infection
11%
McGill Pain Questionnaire
7%
Skinfold Thickness
7%
Body Mass
7%
Intention to Treat Analysis
5%
Adverse Event
5%
Replacement Arthroplasty
5%
Care Group
5%
Sample Size
5%